Division of General Surgery, University Health Network, Toronto, ON, Canada.
Department of Pathology, University Health Network, Toronto, ON, Canada.
Obes Surg. 2020 Jul;30(7):2816-2820. doi: 10.1007/s11695-020-04436-0.
The role of preoperative screening and treatment of Helicobacter pylori (HP) in asymptomatic patients undergoing laparoscopic sleeve gastrectomy (LSG) remains unclear. This study aims to define the preoperative prevalence and management of HP and their effect on postoperative outcomes at our institution.
We reviewed the medical records and surgical specimens of all LSG performed at an academic centre in Toronto, ON between 2010 and 2017.
Review of our institutional database identified 222 patients that underwent LSG, of which 200 had preoperative HP screening: 18% tested positive and 15% were treated. Seven surgical specimens were HP-positive (3.2%). No association was found between preoperative HP status, treatment or HP-positive specimen and postoperative complications at 1 year.
Although preoperative screening and treatment likely reduce the prevalence of HP in LSG specimens, our findings suggest that they may be of limited clinical value in LSG as they have little influence on surgical morbidity.
在接受腹腔镜袖状胃切除术（LSG）的无症状患者中，术前筛查和治疗幽门螺杆菌（HP）的作用仍不清楚。本研究旨在确定我们机构中 HP 的术前患病率和处理方法，以及其对术后结果的影响。
我们回顾了 2010 年至 2017 年期间在安大略省多伦多市的一家学术中心进行的所有 LSG 的病历和手术标本。
对我们机构数据库的审查确定了 222 例接受 LSG 的患者，其中 200 例进行了术前 HP 筛查：18%呈阳性，15%接受了治疗。7 个手术标本 HP 阳性（3.2%）。在 1 年时，术前 HP 状态、治疗或 HP 阳性标本与术后并发症之间未发现相关性。
尽管术前筛查和治疗可能会降低 LSG 标本中 HP 的患病率，但我们的研究结果表明，它们在 LSG 中可能没有太大的临床价值，因为它们对手术发病率的影响很小。
